Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$400M |
| 2 |
Citigroup
C
|
+$395M |
| 3 |
CELG
Celgene Corp
CELG
|
+$360M |
| 4 |
Amazon
AMZN
|
+$347M |
| 5 |
RTX Corp
RTX
|
+$344M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$397M |
| 2 |
Salesforce
CRM
|
+$355M |
| 3 |
TSS
Total System Services, Inc.
TSS
|
+$354M |
| 4 |
ULTI
Ultimate Software Group Inc
ULTI
|
+$349M |
| 5 |
Autodesk
ADSK
|
+$313M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.37% |
| 2 | Financials | 4.87% |
| 3 | Healthcare | 3.8% |
| 4 | Consumer Discretionary | 3.79% |
| 5 | Industrials | 3.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PBCT
926
DELISTED
People's United Financial Inc
PBCT
| $34.5M | 0.02% |
2,053,785
-2,134,662
| -51% | -$35.4M |
|
|
DRNA
927
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $34.4M | 0.02% |
2,185,409
+163,799
| +8% | +$2.23M |
|
928
CALL
Intuit
INTU
$98B
| $34.4M | 0.02% |
131,600
-6,300
| -5% | -$1.6M |
|
929
SPDR Gold Trust
GLD
$142B
| $34.3M | 0.02% |
+257,804
| New | +$31.9M |
|
930
CALL
NetEase
NTES
$79.5B
| $34.3M | 0.02% |
670,500
-216,000
| -24% | -$11.5M |
|
931
CALL
EOG Resources
EOG
$75.1B
| $34.2M | 0.02% |
366,700
+93,500
| +34% | +$8.7M |
|
|
SRC
932
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
| $34.1M | 0.02% |
800,155
+514,965
| +181% | +$21.7M |
|
933
PUT
Match Group
MTCH
$8.4B
| $34.1M | 0.02% |
506,800
+358,000
| +241% | +$23.4M |
|
934
PUT
iShares Silver Trust
SLV
$31.3B
| $34M | 0.02% |
2,370,800
+420,000
| +22% | +$5.86M |
|
935
Cactus
WHD
$5.8B
| $33.9M | 0.02% |
1,024,597
-622,919
| -38% | -$21.7M |
|
936
CALL
Direxion Daily Semiconductor Bull 3X ETF
SOXL
$24.8B
| $33.9M | 0.02% |
3,430,500
+501,000
| +17% | +$4.98M |
|
937
Edgewell Personal Care
EPC
$1.32B
| $33.8M | 0.02% |
1,254,381
+1,025,091
| +447% | +$36.6M |
|
|
MRTX
938
CALL
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $33.7M | 0.02% |
327,600
+292,000
| +820% | +$22.7M |
|
939
New York Times
NYT
$10.3B
| $33.7M | 0.02% |
1,033,206
+437,460
| +73% | +$14.6M |
|
940
CALL
S&P Global
SPGI
$125B
| $33.7M | 0.02% |
147,900
+2,500
| +2% | +$546K |
|
941
Tapestry
TPR
$25.9B
| $33.6M | 0.02% |
1,059,228
+63,412
| +6% | +$1.98M |
|
942
PUT
LendingTree
TREE
$444M
| $33.6M | 0.02% |
80,000
+30,500
| +62% | +$11.7M |
|
|
KYNB
943
Kyntra Bio
KYNB
$28.7M
| $33.6M | 0.02% |
29,707
+27,966
| +1,606% | +$30.6M |
|
944
Dana Inc
DAN
$3.2B
| $33.5M | 0.02% |
1,680,872
+834,973
| +99% | +$14.9M |
|
|
945
Eli Lilly
LLY
$1.08T
| $33.4M | 0.02% |
301,406
-3,372,002
| -92% | -$397M |
|
946
Factset
FDS
$9.89B
| $33.4M | 0.02% |
116,452
+82,936
| +247% | +$23M |
|
947
CALL
General Mills
GIS
$20.4B
| $33.2M | 0.02% |
632,900
-373,900
| -37% | -$19.3M |
|
948
Zions Bancorporation
ZION
$10.5B
| $33.2M | 0.02% |
722,550
-202,604
| -22% | -$9.37M |
|
949
CALL
Cheniere Energy
LNG
$55.4B
| $33.2M | 0.02% |
485,200
+112,900
| +30% | +$7.47M |
|
|
GRUB
950
CALL
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
| $33.2M | 0.02% |
212,850
+48,150
| +29% | +$6.56M |
|
Similar funds
Ken Griffin's Q2 2019 Portfolio in Review
As of Q2 2019, Ken Griffin held 10,425 positions worth $218B, up 8.5% from $201B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Ken Griffin deployed $6.68B of net new capital in Q2 2019, opening 1,217 new positions and adding to 3,775 existing holdings. Its largest new stake was Uber: 7,077,910 shares worth $328M.
By sector, the portfolio is most concentrated in Technology at 5.4% of assets, down from 5.5% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Eli Lilly, an estimated $397M trimmed.
- Ken Griffin's largest Q2 2019 buy was Uber: 7,077,910 shares worth $328M.
- Ken Griffin added most to Netflix in Q2 2019, an estimated $400M increase.
- Ken Griffin's biggest Q2 2019 reduction was Eli Lilly, cutting an estimated $397M.
- Ken Griffin fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $349M.
- Ken Griffin's ten largest holdings make up 23% of its $218B portfolio in Q2 2019.
- Ken Griffin opened 1,217 new positions and closed 1,335 in Q2 2019.
- Ken Griffin's portfolio value rose 8.5% quarter-over-quarter to $218B.
Based on Citadel Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.